Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NYSTATIN for Vulvovaginal candidiasis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where NYSTATIN was used for Vulvovaginal candidiasis.

Most Reported Side Effects for NYSTATIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 330 17.4% 29 69
Off label use 149 7.9% 19 53
Dyspnoea 148 7.8% 11 54
Candida infection 145 7.7% 14 19
Nausea 120 6.3% 7 60
Rash 120 6.3% 16 32
Drug hypersensitivity 102 5.4% 7 25
Cough 91 4.8% 1 17
Asthma 90 4.8% 3 24
Condition aggravated 90 4.8% 13 24
Pulmonary embolism 86 4.6% 10 12
Pain 82 4.3% 4 28
Fatigue 81 4.3% 4 41
Pruritus 81 4.3% 6 30
Sinusitis 81 4.3% 4 29

Other Indications for NYSTATIN

Product used for unknown indication (626) Oral candidiasis (166) Candida infection (164) Fungal infection (87) Prophylaxis (38) Antifungal prophylaxis (34) Rash (28) Pain in extremity (27) Fungal skin infection (24) Mouth ulceration (21)

Other Drugs Used for Vulvovaginal candidiasis

FLUCONAZOLE (398) CLOTRIMAZOLE (37) ITRACONAZOLE (26) OTESECONAZOLE (14) IBREXAFUNGERP (9) MICONAZOLE (9) ECONAZOLE (8) REZAFUNGIN (7)

Related Pages

NYSTATIN Full Profile All Vulvovaginal candidiasis Drugs NYSTATIN Demographics NYSTATIN Timeline